Chargement en cours...
Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols
Rationale: lactose is the only FDA-approved carrier for dry powder inhaler (DPI) formulations in the US. Lactose carrier-based DPI products are contraindicated in patients with a known lactose allergy. Hence, inhaler formulations without lactose will benefit lactose allergic asthmatics. Objectives:...
Enregistré dans:
| Publié dans: | RSC Adv |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Royal Society of Chemistry
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7689944/ https://ncbi.nlm.nih.gov/pubmed/33391731 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d0ra07203f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|